Literature DB >> 15770443

Coccidioidomycosis of the male reproductive tract.

Eric S Halsey1, Mark S Rasnake, Duane R Hospenthal.   

Abstract

Coccidioides immitis infection of the male reproductive tract is a rare entity that can evade diagnosis and pose a dilemma in management. Initially, patients are often evaluated for malignancy or other infections such as tuberculosis. In the past, surgery was the only management option for C. immitis infection of the male reproductive tract, but azole therapy now provides an adjunct or an alternative. We describe two patients who received azole therapy for C. immitis infection of the male reproductive tract. One received fluconazole for prostatic disease, while one received surgery followed by itraconazole for testicular disease. After 12 months of therapy, both remain asymptomatic and have decreased antibody titers against C. immitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15770443     DOI: 10.1007/s11046-004-6260-0

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  1 in total

Review 1.  Coccidioidomycosis.

Authors:  D A Stevens
Journal:  N Engl J Med       Date:  1995-04-20       Impact factor: 91.245

  1 in total
  3 in total

1.  Disseminated coccidioidomycosis in an immunodeficient 16-year-old female.

Authors:  Ian L Musil; Dorothy Gilbertson-Dahdal; Sean P Elliott
Journal:  Radiol Case Rep       Date:  2015-12-07

2.  Coccidioidomycosis in Biopsies with Presumptive Diagnosis of Malignancy in Dogs: Report of Three Cases and Comparative Discussion of Published Reports.

Authors:  Rafael Ramírez-Romero; Rolando Antonio Silva-Pérez; Jorge Lara-Arias; Cecilia Ramírez-Hernández; Iván Alberto Marino-Martínez; Álvaro Barbosa-Quintana; Alfonso López-Mayagoitia
Journal:  Mycopathologia       Date:  2015-09-29       Impact factor: 2.574

3.  Rare Dysuria: Prostatic Abscess due to Disseminated Coccidioidomycosis.

Authors:  Pedram Ansari Pirsaraei; Kareem Tabsh; Jacob Lentz
Journal:  Urol Case Rep       Date:  2016-08-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.